Table 3 Clinical features of patients treated
Age (years) | |
⩽39 | 226 (90.4%) |
>39 | 24 (9.6) |
Antecedent pregnancy | |
Mole | 234 (93.6) |
Term | 1 (0.4%) |
Termination | 2 (0.8%) |
Ectopic pregnancy | 5 (4 molar ectopics, 1 not known) (2%) |
Other (unspecified/no molar tissue) | 8 (3.2%) |
Evacuations | |
Mean | 2.16 |
Median | 2 |
Time from first evacuation to treatment (months) | |
<4 | 169 (67.6%) |
4−6 | 51 (20.4%) |
6−12 | 24 (9.6%) |
>12 | 4 (1.6%) |
No evacuation | 2 (0.8%) |
βhCG (IU l−1) | |
103−104 | 89 (35.6%) |
<103 | 59 (23.6%) |
104−105 | 95 (38%) |
>105 | 7 (2.8%) |
Number of metastases | |
Nil | 178 (71.2%) |
1−4 | 53 (21.2%) |
4−8 | 16 (6.4%) |
>8 | 2 (0.8%) |
Unknown | 1 (0.4%) |
Methotrexate courses | |
Mean | 8 |
Median | 7 |
Range | 1−14 |
